Barclays PLC grew its stake in shares of Sapiens International Co. (NASDAQ:SPNS – Free Report) by 415.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,640 shares of the technology company’s stock after buying an additional 44,033 shares during the period. Barclays PLC owned 0.10% of Sapiens International worth $2,036,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. National Bank of Canada FI purchased a new position in Sapiens International during the third quarter valued at approximately $26,000. Financial Management Professionals Inc. raised its position in shares of Sapiens International by 57.9% during the 3rd quarter. Financial Management Professionals Inc. now owns 1,945 shares of the technology company’s stock valued at $72,000 after purchasing an additional 713 shares during the period. Morgan Dempsey Capital Management LLC lifted its stake in shares of Sapiens International by 9.5% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,206 shares of the technology company’s stock valued at $143,000 after buying an additional 365 shares in the last quarter. MQS Management LLC bought a new position in Sapiens International in the 3rd quarter worth $230,000. Finally, HighTower Advisors LLC purchased a new stake in Sapiens International in the 3rd quarter worth $231,000. 30.73% of the stock is currently owned by institutional investors.
Sapiens International Stock Up 0.5 %
Shares of SPNS opened at $27.59 on Friday. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.18 and a quick ratio of 2.18. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 21.72 and a beta of 1.15. Sapiens International Co. has a 1 year low of $26.34 and a 1 year high of $41.22. The business’s 50 day simple moving average is $31.15 and its 200-day simple moving average is $34.25.
Analyst Ratings Changes
Several equities analysts have recently commented on the company. StockNews.com downgraded Sapiens International from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 19th. Barclays dropped their price target on Sapiens International from $38.00 to $30.00 and set an “underweight” rating for the company in a research note on Tuesday, November 12th. Needham & Company LLC reduced their price objective on shares of Sapiens International from $44.00 to $35.00 and set a “buy” rating on the stock in a research report on Tuesday, November 12th. Finally, William Blair restated a “market perform” rating on shares of Sapiens International in a research report on Friday, December 6th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, Sapiens International presently has an average rating of “Hold” and an average price target of $36.00.
Read Our Latest Analysis on Sapiens International
Sapiens International Company Profile
Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields.
Read More
- Five stocks we like better than Sapiens International
- How to trade using analyst ratings
- Top 3 Investment Themes to Watch for in 2025
- Following Congress Stock Trades
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.